204 related articles for article (PubMed ID: 7883559)
1. The Utah Thyroid Cohort Study: analysis of the dosimetry results.
Till JE; Simon SL; Kerber R; Lloyd RD; Stevens W; Thomas DC; Lyon JL; Preston-Martin S
Health Phys; 1995 Apr; 68(4):472-83. PubMed ID: 7883559
[TBL] [Abstract][Full Text] [Related]
2. A cohort study of thyroid disease in relation to fallout from nuclear weapons testing.
Kerber RA; Till JE; Simon SL; Lyon JL; Thomas DC; Preston-Martin S; Rallison ML; Lloyd RD; Stevens W
JAMA; 1993 Nov; 270(17):2076-82. PubMed ID: 8411574
[TBL] [Abstract][Full Text] [Related]
3. Development of a method to estimate thyroid dose from fallout radioiodine in a cohort study.
Simon SL; Lloyd RD; Till JE; Hawthorne HA; Gren DC; Rallison ML; Stevens W
Health Phys; 1990 Nov; 59(5):669-91. PubMed ID: 2211123
[TBL] [Abstract][Full Text] [Related]
4. Thyroid cancer rates and 131I doses from Nevada atmospheric nuclear bomb tests.
Gilbert ES; Tarone R; Bouville A; Ron E
J Natl Cancer Inst; 1998 Nov; 90(21):1654-60. PubMed ID: 9811315
[TBL] [Abstract][Full Text] [Related]
5. Cohort study of thyroid disease near the Nevada Test Site: a preliminary report.
Rallison ML; Lotz TM; Bishop M; Divine W; Haywood K; Lyon JL; Stevens W
Health Phys; 1990 Nov; 59(5):739-46. PubMed ID: 2211127
[TBL] [Abstract][Full Text] [Related]
6. Thyroid cancer risk in the population around the Nevada Test Site.
Zeighami EA; Morris MD
Health Phys; 1986 Jan; 50(1):19-32. PubMed ID: 3943971
[TBL] [Abstract][Full Text] [Related]
7. Testing prediction capabilities of an 131I terrestrial transport model by using measurements collected at the Hanford nuclear facility.
Apostoaei AI
Health Phys; 2005 May; 88(5):439-58. PubMed ID: 15824593
[TBL] [Abstract][Full Text] [Related]
8. The Utah Leukemia Case-Control Study: dosimetry methodology and results.
Simon SL; Till JE; Lloyd RD; Kerber RL; Thomas DC; Preston-Martin S; Lyon JL; Stevens W
Health Phys; 1995 Apr; 68(4):460-71. PubMed ID: 7883558
[TBL] [Abstract][Full Text] [Related]
9. Thyroid Doses to French Polynesians Resulting from Atmospheric Nuclear Weapons Tests: Estimates Based on Radiation Measurements and Population Lifestyle Data.
Drozdovitch V; Bouville A; Taquet M; Gardon J; Xhaard C; Ren Y; Doyon F; de Vathaire F
Health Phys; 2021 Jan; 120(1):34-55. PubMed ID: 33002966
[TBL] [Abstract][Full Text] [Related]
10. Thyroid disease associated with exposure to the Nevada nuclear weapons test site radiation: a reevaluation based on corrected dosimetry and examination data.
Lyon JL; Alder SC; Stone MB; Scholl A; Reading JC; Holubkov R; Sheng X; White GL; Hegmann KT; Anspaugh L; Hoffman FO; Simon SL; Thomas B; Carroll R; Meikle AW
Epidemiology; 2006 Nov; 17(6):604-14. PubMed ID: 17028502
[TBL] [Abstract][Full Text] [Related]
11. Perspective: National Cancer Institute summary report about estimated exposures and thyroid doses received from iodine 131 in fallout after Nevada atmospheric nuclear bomb tests.
Hundahl SA
CA Cancer J Clin; 1998; 48(5):285-98. PubMed ID: 9742895
[TBL] [Abstract][Full Text] [Related]
12. Reconstruction of individual radiation doses for a case-control study of thyroid cancer in French Polynesia.
Drozdovitch V; Bouville A; Doyon F; Brindel P; Cardis E; de Vathaire F
Health Phys; 2008 May; 94(5):418-33. PubMed ID: 18403963
[TBL] [Abstract][Full Text] [Related]
13. Radiation doses and cancer risks in the Marshall Islands associated with exposure to radioactive fallout from Bikini and Enewetak nuclear weapons tests: summary.
Simon SL; Bouville A; Land CE; Beck HL
Health Phys; 2010 Aug; 99(2):105-23. PubMed ID: 20622547
[TBL] [Abstract][Full Text] [Related]
14. 2004 update of dosimetry for the Utah Thyroid Cohort Study.
Simon SL; Anspaugh LR; Hoffman FO; Scholl AE; Stone MB; Thomas BA; Lyon JL
Radiat Res; 2006 Feb; 165(2):208-22. PubMed ID: 16435919
[TBL] [Abstract][Full Text] [Related]
15. Reconstruction of radiation doses in a case-control study of thyroid cancer following the Chernobyl accident.
Drozdovitch V; Khrouch V; Maceika E; Zvonova I; Vlasov O; Bratilova A; Gavrilin Y; Goulko G; Hoshi M; Kesminiene A; Shinkarev S; Tenet V; Cardis E; Bouville A
Health Phys; 2010 Jul; 99(1):1-16. PubMed ID: 20539120
[TBL] [Abstract][Full Text] [Related]
16. Overview of the National Cancer Institute's activities related to exposure of the public to fallout from the Nevada Test Site.
Wachholz BW
Health Phys; 1990 Nov; 59(5):511-4. PubMed ID: 2211110
[TBL] [Abstract][Full Text] [Related]
17. Thyroid cancer rates and 131I doses from Nevada atmospheric nuclear bomb tests: an update.
Gilbert ES; Huang L; Bouville A; Berg CD; Ron E
Radiat Res; 2010 May; 173(5):659-64. PubMed ID: 20426666
[TBL] [Abstract][Full Text] [Related]
18. A post-Chernobyl rise in thyroid cancer in Connecticut, USA.
Mangano JJ
Eur J Cancer Prev; 1996 Feb; 5(1):75-81. PubMed ID: 8664814
[TBL] [Abstract][Full Text] [Related]
19. Estimates of fallout in the continental U.S. from Nevada weapons testing based on gummed-film monitoring data.
Beck HL; Helfer IK; Bouville A; Dreicer M
Health Phys; 1990 Nov; 59(5):565-76. PubMed ID: 2211116
[TBL] [Abstract][Full Text] [Related]
20. Estimates of exposure rates and fallout arrival times near the Nevada Test Site.
Thompson CB
Health Phys; 1990 Nov; 59(5):555-63. PubMed ID: 2211115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
